Paola, S.-R.C. et al. 2020. Clinical Response to Osimertinib Compared to Other Tyrosine Kinase Inhibitors and Chemotherapy in Non-Small Cell Lung Cancer. Archives of Clinical and Medical Case Reports. 4, 6 (Nov. 2020), 1108–1115.